Furthermore, TGF‐β downregulates Cav‐1 expression and stimulates increased levels of pigment epithelium‐derived factor (PEDF) in dermal fibroblasts, which inhibits angiogenesis in SSc [85]. This evidence concerns the gene TGFB1 and systemic sclerosis.